These analyses revealed that the prognostic impact of FAM13C expression was strong in cancers lacking PTEN deletions (p < 0.0001 Figure 6.4), and was still statistically significant in the smaller subgroup of tumors harboring PTEN deletions (p = 0.0212, Figure 6.5). This evidence concerns the gene PTEN and cancer.